CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single arm, multi-centre, phase II open label study of nivolumab with stereotactic body radiotherapy (SBRT) for early stage non-sm ...
Phase 1, Phase 2
Sutton, United Kingdom
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
London, England, United Kingdom and 59 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
London, United Kingdom and 209 other locations
medicinal product\]) in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
London, United Kingdom and 37 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
London, United Kingdom and 138 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
London, Greater London, United Kingdom and 126 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
London, United Kingdom and 123 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
London, United Kingdom and 242 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
London, United Kingdom and 263 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
London, United Kingdom and 169 other locations
Clinical trials
Research sites
Resources
Legal